Insiders · Profile

Parsey Merdad

Chief Medical Officer at Gilead Sciences. Filing since 17 Aug 2020. CIK 0001792150

Company

Date

Role

Action

Shares

Amount

Of holding

GILD Gilead Sciences

27 Nov 2024

Chief Medical Officer

Sold on a plan

164,211

$15.09M

67.0%

GILD Gilead Sciences

6 Nov 2024

Chief Medical Officer

Sold on a plan

25,590

$2.34M

20.4%

GILD Gilead Sciences

1 Oct 2024

Chief Medical Officer

Sold on a plan

2,000

$167.66K

2.0%

GILD Gilead Sciences

12 Sep 2024

Chief Medical Officer

Sold on a plan

21,246

$1.80M

17.2%

GILD Gilead Sciences

1 Jul 2024

Chief Medical Officer

Sold on a plan

2,000

$137.26K

2.0%

GILD Gilead Sciences

1 Apr 2024

Chief Medical Officer

Sold on a plan

2,000

$145.92K

2.0%

GILD Gilead Sciences

29 Feb 2024

Chief Medical Officer

Sold on a plan

8,230

$598.62K

8.2%

GILD Gilead Sciences

28 Feb 2024

Chief Medical Officer

Sold on a plan

2,000

$146.36K

1.9%

GILD Gilead Sciences

12 Sep 2023

Chief Medical Officer

Sold on a plan

1,501

$115.56K

2.1%

GILD Gilead Sciences

13 Jun 2023

Chief Medical Officer

Sold on a plan

1,485

$114.20K

4.8%

GILD Gilead Sciences

13 Mar 2023

Chief Medical Officer

Sold, plan not stated

6,126

$483.89K

8.0%

GILD Gilead Sciences

1 Mar 2023

Chief Medical Officer

Sold, plan not stated

12,984

$1.04M

15.6%

GILD Gilead Sciences

30 Dec 2022

Chief Medical Officer

Sold, plan not stated

553

$47.19K

1.2%

GILD Gilead Sciences

17 Aug 2020

Chief Medical Officer

Sold, plan not stated

182

$12.43K

100%

14 decisions on file.